Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Hassel

Showing results (1-10 of 272) with videos related to

Pageof 28
Sort By:
British Journal of Cancer|October 26, 2021
Checkpoint blocker induced autoimmunity as an indicator for tumour efficacy in melanomaJessica C Hassel
The Lancet. Oncology|July 27, 2019
5-year results for pembrolizumab treatment of advanced melanomaJessica C Hassel
The Lancet. Oncology|September 13, 2016
Ipilimumab plus nivolumab for advanced melanomaJessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 16, 2022
Neues vom ASCO 2022 für die Dermato OnkologieRalf Gutzmer, Jessica C Hassel
Deutsches Arzteblatt International|February 22, 2022
Malignant Changes in the Hard PalateEnrico Streit, Jessica C Hassel
Frontiers in Oncology|February 10, 2023
Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patientsDevayani Machiraju, Jessica C Hassel
Pathologie (Heidelberg, Germany)|June 18, 2026
[Therapy of melanoma : Current standards and future perspectives]Isabel Hariri, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 13, 2023
Neues vom AACR und ASCO 2023 für die Dermato-OnkologieRalf Gutzmer, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 19, 2022
Tebentafusp als neuartige Immuntherapie zeigt einen Überlebensvorteil beim metastasierten Uveamelanom und wird bereits in Deutschland eingesetztJessica C Hassel, Carola Berking
Current Treatment Options in Oncology|April 5, 2022
Targeted Therapy for Melanomas Without BRAF V600 MutationsChristian Menzer, Jessica C Hassel
Pageof 28

Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
British Journal of Cancer|October 26, 2021
Checkpoint blocker induced autoimmunity as an indicator for tumour efficacy in melanomaJessica C Hassel
The Lancet. Oncology|July 27, 2019
5-year results for pembrolizumab treatment of advanced melanomaJessica C Hassel
The Lancet. Oncology|September 13, 2016
Ipilimumab plus nivolumab for advanced melanomaJessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 16, 2022
Neues vom ASCO 2022 für die Dermato OnkologieRalf Gutzmer, Jessica C Hassel
Deutsches Arzteblatt International|February 22, 2022
Malignant Changes in the Hard PalateEnrico Streit, Jessica C Hassel
Frontiers in Oncology|February 10, 2023
Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patientsDevayani Machiraju, Jessica C Hassel
Pathologie (Heidelberg, Germany)|June 18, 2026
[Therapy of melanoma : Current standards and future perspectives]Isabel Hariri, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 13, 2023
Neues vom AACR und ASCO 2023 für die Dermato-OnkologieRalf Gutzmer, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 19, 2022
Tebentafusp als neuartige Immuntherapie zeigt einen Überlebensvorteil beim metastasierten Uveamelanom und wird bereits in Deutschland eingesetztJessica C Hassel, Carola Berking
Current Treatment Options in Oncology|April 5, 2022
Targeted Therapy for Melanomas Without BRAF V600 MutationsChristian Menzer, Jessica C Hassel
Pageof 28